180 related articles for article (PubMed ID: 20522011)
1. Transgenic mouse models of Parkinson's disease and Huntington's disease.
Skaper SD; Giusti P
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):455-70. PubMed ID: 20522011
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease.
Thomas B; Beal MF
Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
[TBL] [Abstract][Full Text] [Related]
3. Mouse models of Huntington's disease.
Menalled LB; Chesselet MF
Trends Pharmacol Sci; 2002 Jan; 23(1):32-9. PubMed ID: 11804649
[TBL] [Abstract][Full Text] [Related]
4. The molecular biology of Huntington's disease.
Ho LW; Carmichael J; Swartz J; Wyttenbach A; Rankin J; Rubinsztein DC
Psychol Med; 2001 Jan; 31(1):3-14. PubMed ID: 11200958
[TBL] [Abstract][Full Text] [Related]
5. Mouse Models of Huntington's Disease.
Farshim PP; Bates GP
Methods Mol Biol; 2018; 1780():97-120. PubMed ID: 29856016
[TBL] [Abstract][Full Text] [Related]
6. Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy.
Chang R; Liu X; Li S; Li XJ
Drug Des Devel Ther; 2015; 9():2179-88. PubMed ID: 25931812
[TBL] [Abstract][Full Text] [Related]
7. Knock-in mouse models of Huntington's disease.
Menalled LB
NeuroRx; 2005 Jul; 2(3):465-70. PubMed ID: 16389309
[TBL] [Abstract][Full Text] [Related]
8. Selective neuronal degeneration in Huntington's disease.
Cowan CM; Raymond LA
Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.
Peng Q; Wu B; Jiang M; Jin J; Hou Z; Zheng J; Zhang J; Duan W
PLoS One; 2016; 11(2):e0148839. PubMed ID: 26859386
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
Mo C; Renoir T; Hannan AJ
Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
[TBL] [Abstract][Full Text] [Related]
11. Environmental factors as modulators of neurodegeneration: insights from gene-environment interactions in Huntington's disease.
Mo C; Hannan AJ; Renoir T
Neurosci Biobehav Rev; 2015 May; 52():178-92. PubMed ID: 25770041
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.
Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR
Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107
[TBL] [Abstract][Full Text] [Related]
13. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
14. Molecular mediators, environmental modulators and experience-dependent synaptic dysfunction in Huntington's disease.
Hannan AJ
Acta Biochim Pol; 2004; 51(2):415-30. PubMed ID: 15218539
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in Huntington's disease.
Gutekunst CA; Norflus F; Hersch SM
Curr Opin Neurol; 2000 Aug; 13(4):445-50. PubMed ID: 10970063
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in Huntington's and Parkinson's Disease.
O'Keeffe GC; Michell AW; Barker RA
Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in understanding the pathogenesis of Huntington's disease.
Reddy PH; Williams M; Tagle DA
Trends Neurosci; 1999 Jun; 22(6):248-55. PubMed ID: 10354600
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
Nithianantharajah J; Hannan AJ
Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
[TBL] [Abstract][Full Text] [Related]
20. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
Crocker SF; Costain WJ; Robertson HA
Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]